
GulfBio · GB-TESAMORELIN-10MG
Tesamorelin 10mg
Taxes included. Shipping calculated at checkout.
Prices are set in USD. Local-currency amounts are indicative conversions for guidance only.
Shipped in discreet, unbranded packaging — no company name or product description on the outer box.
In stock
Quantity (0 in cart)
Description
A synthetic 44-amino acid analogue of Growth Hormone-Releasing Factor (GRF) designed for research into growth hormone secretion and lipid metabolism.
Tesamorelin 10mg is a synthetic analogue of Growth Hormone-Releasing Factor (GRF). It is comprised of the first 44 amino acids of human GRF with the addition of a trans-3-hexenoic acid group at the N-terminal position. This specific modification enhances its stability and resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4), thereby increasing its biological half-life compared to the endogenous peptide. In laboratory research settings, Tesamorelin is primarily investigated for its ability to stimulate the pituitary gland to synthesize and secrete endogenous growth hormone (GH) in a pulsatile manner. Because it acts directly on the GHRH receptors, it maintains the natural feedback mechanisms of the GH-IGF-1 axis, making it a focal point for studies involving metabolic regulation and adipose tissue distribution.
Product Overview
Tesamorelin 10mg is a stabilized synthetic peptide analogue of growth hormone-releasing hormone (GHRH). It is provided in a highly purified, lyophilised format intended for laboratory experimentation. As a growth hormone secretagogue, it is widely utilized in in vitro and in vivo studies to observe its influence on growth hormone production and metabolic signaling pathways.
Specifications
Form: Lyophilised Powder Quantity: 10mg Purity: ≥99% (HPLC) Molecular Formula: C221H366N72O67S Storage: Store in a cool, dry place, away from direct light. For long-term stability, ensure the vial remains sealed in a controlled environment.
Research Applications
Research literature indicates that Tesamorelin is extensively studied for its impact on abdominal fat reduction and lipodystrophy. Scientists utilize this compound to explore the mechanisms of lipolysis, insulin sensitivity, and the potential neuroprotective effects associated with increased levels of insulin-like growth factor 1 (IGF-1). Furthermore, it is a subject of interest in research regarding cognitive health and the attenuation of age-related metabolic decline.
Certificate of Analysis
Review the batch documentation for identity and purity details.
COAs available upon request — contact GulfBio Support.
Research Use Notice
For laboratory research use only. Not for human or veterinary use.
Related items

Vials
Retatrutide 10mg
A potent triple-receptor agonist (GLP-1, GIP, and Glucagon) supplied as a 10mg lyophilised powder for metabolic research applications.

Vials
Retatrutide 15mg
A potent 15mg triple agonist peptide (GLP-1, GIP, and GCG) designed for advanced metabolic and endocrine research applications.

Vials
Retatrutide 20mg
A potent triple-hormone agonist (GLP-1/GIP/GCG) provided in a 20mg vial for advanced metabolic and biochemical research.
